NVIDIA received US permission to sell H200 AI chips to approved Chinese firms including New Matrix, but The Verge Tech reports that New Matrix's physical offices appear empty, raising due diligence questions for US regulators. The arrangement casts doubt on the efficacy of current export controls and buyer verification. The news amplifies both biosecurity and competitive risks tied to global chip flows.
Why it matters. Investors should monitor for additional regulatory interventions or sanctions as scrutiny tightens on AI chip sales; chipmakers’ China sales could be repriced if compliance or enforcement changes. Reported